Format

Send to

Choose Destination
JAMA Intern Med. 2019 Aug 5. doi: 10.1001/jamainternmed.2019.3107. [Epub ahead of print]

Potential Medicare Savings From Generic Substitution and Therapeutic Interchange of ACE Inhibitors and Angiotensin-II-Receptor Blockers.

Author information

1
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
2
Harvard Medical School Multi-Campus Geriatric Fellowship, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
3
Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston.
PMID:
31380893
PMCID:
PMC6686978
[Available on 2020-08-05]
DOI:
10.1001/jamainternmed.2019.3107

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center